Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics. (Q33358185)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics. |
scientific article |
Statements
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics (English)
Robert J Morgan
James H Doroshow
Timothy Synold
Dean Lim
Stephen Shibata
Kim Margolin
Roderich Schwarz
Lucille Leong
George Somlo
Przemyslaw Twardowski
Yun Yen
Warren Chow
Paul Lin
Benjamin Paz
David Chu
Paul Frankel
1 December 2003